Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Recruiting now

Conditions studied: AAA - Abdominal Aortic Aneurysm

In brief

A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.

Key facts

Study ID: NCT06218875
Run by: W.L.Gore & Associates
People needed: 2000
Starts: 2024-05-07
Expected to finish: 2042-09-30
Last updated by the study team: 2026-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
Patient has been or is intended to be treated with an eligible registry device
Patient is age ≥ 18 years at time of informed consent signature.

You may not qualify if…

Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.
Patient with exclusion criteria required by local law.
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.

Where it is running

University of California - Irvine — Irvine, California, United States (enrolling)
University of Southern California — Los Angeles, California, United States (enrolling)
University of Southern California — Los Angeles, California, United States (enrolling)
Stanford University School of Medicine — Palo Alto, California, United States (enrolling)
Stanford University School of Medicine — Stanford, California, United States (enrolling)
Mount Sinai Vascular Institute — Miami Beach, Florida, United States (enrolling)
University of South Florida — Tampa, Florida, United States (enrolling)
University of South Florida — Tampa, Florida, United States (enrolling)
VA Medical Center- Atlanta — Atlanta, Georgia, United States (enrolling)
Emory Saint Joseph's Hospital — Atlanta, Georgia, United States (enrolling)
Augusta University Medical Center — Augusta, Georgia, United States (enrolling)
Atlanta VA Medical Center — Decatur, Georgia, United States (enrolling)
University of Chicago Hospital — Chicago, Illinois, United States (enrolling)
Endeavor Health — Evanston, Illinois, United States (enrolling)
St. Vincent Medical Group, Inc. — Indianapolis, Indiana, United States (enrolling)
University of Louisville — Louisville, Kentucky, United States (enrolling)
Our Lady of the Lake Regional Medical Center — Baton Rouge, Louisiana, United States (enrolling)
University of Maryland - Baltimore — Baltimore, Maryland, United States (enrolling)
Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)
Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)
McLaren Heatlh Care Corporation — Bay City, Michigan, United States (enrolling)
Corewell Health Medical Group West — Grand Rapids, Michigan, United States (enrolling)
Minneapolis Heart Institute Foundation — Minneapolis, Minnesota, United States (enrolling)
Mayo Clinic — Rochester, Minnesota, United States (enrolling)
Central Arkansas Veteran's Healthcare System — Little Rock, Arkansas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.